Aspiro Pharma recalls

FDA enforcement reports naming Aspiro Pharma Limited as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Oct 29, 2025

Severity

Oct 29, 2025Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, Fo…Drug · Aspiro Pharma LimitedPresence of Particulate Matter: Particulate matter identified as glassClass II